Cargando…
Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo
An imbalance in von Willebrand factor (VWF) may either lead to bleeding (von Willebrand disease, VWD) or thrombosis. Both disorders have shortcomings in the currently available treatments. VWF itself could be a potential therapeutic target because of its role in both bleeding and thrombosis. Inhibit...
Autores principales: | Jongejan, Yvonne K., Schrader Echeverri, Elisa, Dirven, Richard J., Paunovska, Kalina, Linthorst, Noa A., de Jong, Annika, Wellershoff, Johannes C., van der Gouw, Kim D., van Vlijmen, Bart J. M., Dahlman, James E., Eikenboom, Jeroen C. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582391/ https://www.ncbi.nlm.nih.gov/pubmed/37467023 http://dx.doi.org/10.1182/bloodadvances.2023010643 |
Ejemplares similares
-
Assembly of von Willebrand factor tubules with in vivo helical parameters requires A1 domain insertion
por: Javitt, Gabriel, et al.
Publicado: (2022) -
Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2022) -
Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022) -
Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2
por: Seidizadeh, Omid, et al.
Publicado: (2022) -
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
por: Falter, Tanja, et al.
Publicado: (2023)